LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged financial services and business methods · clear

Federal Circuit

Patent Claims Reordering Conventional Steps May Be Ineligible Under 101

SOLUTRAN, INC v. ELAVON, INC. Before Chen , Hughes, and Stoll. Appeal from the United States District Court for the District of Minnesota Summary: Method claims directed to performing conventional steps in a new order may be insufficient to render claims…

July 30, 2019·Federal Circuit·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.